tDCS has been reported to be neuroprotective in many experimental neurological diseases, by reducing caspase-3 positive neurons after ischemia/reperfusion injury and by alleviating cerebral inflammation and neuronal apoptosis. The gene discussed is CASP3; the disease is nervous system disorder.